TRPV1 and chronic obstructive pulmonary disease: Clinically, elevation of both pulmonary endogenous TRPV1 stimulants and PGE2 has been believed to be responsible for coughs in patients with asthma, idiopathic pulmonary fibrosis, and COPD [27].